Log In
BCIQ
Print this Print this
 

Mobilan

  Manage Alerts
Collapse Summary General Information
Company Cleveland BioLabs Inc.
DescriptionNanoparticle-formulated recombinant non-replicating adenovirus
Molecular Target
Mechanism of Action 
Therapeutic ModalityGene therapy: Viral vector: Adenovirus
Latest Stage of DevelopmentPhase I
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today